www.fdanews.com/articles/196906-binx-healths-std-diagnostic-earns-additional-fda-clearance
Binx Health’s STD Diagnostic Earns Additional FDA Clearance
May 1, 2020
Binx Health’s binx io molecular point-of-care testing system has received FDA clearance for detecting chlamydia and gonorrhea in men.
The system delivers lab-quality results from urine samples in approximately half an hour.
Binx previously received agency clearance in August 2019 for detecting chlamydia and gonorrhea in women.